$11.55
0.090.79%
At Close: -
$11.93
0.383.29%
After Hours: 7:48 PM EDT
15 minutes delayed
Comments
Loading...
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock, Earnings Estimates, EPS, And Revenue
Phathom Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-1.380
Quarterly Revenue Estimate
$5.7M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.6M
Analyze the earnings history of Phathom Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals | -$0.84 | -$1.38 | — | — | $0.00 | $5.66M | — | — | 08/12/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.89 | -$1.24 | -$1.42 | — | $0.00 | $2.05M | $1.91M | -6.73% | 05/09/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.33 | -$1.08 | -$1.39 | -28.70% | $0.00 | $410.00K | $682.00K | 66.34% | 03/07/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.32 | -$0.89 | -$0.76 | 14.61% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.33 | -$1.00 | -$0.84 | 16.00% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.07 | -$1.26 | -$0.89 | 29.37% | $0.00 | — | $0.00 | — | 05/10/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.95 | -$1.35 | -$1.33 | 1.48% | $0.00 | — | $0.00 | — | 02/28/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.98 | -$1.32 | -$1.32 | 0.00% | $0.00 | — | $0.00 | — | 11/08/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.00 | -$1.03 | -$1.33 | -29.13% | $0.00 | — | $0.00 | — | 08/02/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.96 | -$0.97 | -$1.07 | -10.31% | $0.00 | $210.00K | $0.00 | -100.00% | 05/10/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.58 | -$1.03 | -$0.95 | 7.77% | $0.00 | — | $0.00 | — | 03/01/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.02 | -$0.98 | -$0.98 | 0.00% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.64 | -$1.07 | -$1.00 | 6.54% | $0.00 | — | $0.00 | — | 08/10/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.62 | -$1.19 | -$0.96 | 19.33% | $0.00 | — | $0.00 | — | 05/11/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$3.97 | — | -$1.58 | — | $0.00 | — | $0.00 | — | 03/30/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.07 | — | -$1.02 | — | $0.00 | — | $0.00 | — | 11/10/2020 | Get Alert |
| PHAT | Phathom Pharmaceuticals | — | — | -$0.64 | — | — | — | $0.00 | — | 08/06/2020 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.19 | — | -$0.62 | — | — | — | $0.00 | — | 05/12/2020 | Get Alert |
| PHAT | Phathom Pharmaceuticals | — | — | -$3.97 | — | — | — | $0.00 | — | 03/19/2020 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.04 | — | -$1.07 | — | — | — | $0.00 | — | 11/25/2019 | Get Alert |
Phathom Pharmaceuticals (PHAT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-03-07 | $-1.39 | $-1.08 | -28.7 % |
| Sep 2023 | 2023-11-09 | $-0.76 | $-0.89 | 14.6 % |
| Jun 2023 | 2023-08-10 | $-0.84 | $-1.00 | 16.0 % |
| Mar 2023 | 2023-05-10 | $-0.89 | $-1.26 | 29.4 % |
Phathom Pharmaceuticals (PHAT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $1.91M | $2.05M | -6.73 % |
| Dec 2023 | 2024-03-07 | $682.00K | $410.00K | 66.3 % |
| Mar 2022 | 2022-05-10 | $0 | $210.00K | -100.0 % |
FAQ
When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?
Phathom Pharmaceuticals (PHAT) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Phathom Pharmaceuticals (NASDAQ:PHAT)?
The Actual EPS was $-1.42, which missed the estimate of $-1.24.
What were Phathom Pharmaceuticals’s (NASDAQ:PHAT) revenues?
The Actual Revenue was $1.9M, which missed the estimate of $2M.
Browse earnings estimates, EPS, and revenue on all stocks.